Saturday, September 08, 2018 7:49:22 PM
I don't know if a cannabis based drug for GVHD would have made my recovery any better, but I would have tried it if it was available, and my Dr. had agreed. I did note that he was referenced for a paper he'd had a part in writing in the presentation linked on the company website. I've let him know about it and he planned to look into it.
Someone mentioned a planed Phase 3, can anyone tell me what's happening, or provide a link if it's on the clinical trials database. Even with insurance the meds for GVHD were among the most expensive drugs I took, though my costs weren't very high. I don't know that they'd be any cheaper if covered by insurance but cannabis based, but if insurance didn't apply the cannabis based product would certainly be more expensive.
I'm now down to seeing my Dr. 4 times a year unless I'm having some complication, each time he's still looking at certain things for a sign that I'm having a rejection issue. I don't know if cannabis will have benefits there, but I do take a small amount of it to help with muscle aches I get from taking the chemo, the generic for Gleevec, that I'm continuing on. I don't know that they'll ever recommend stopping the drug, but on special occasions I'm permitted to go off it for short periods and the muscle aches practically disappear.
I welcome any information before I invest, I'm still looking at the company.
Gary
FEATURED POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • Mar 27, 2024 10:52 AM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM